Bioassay offers one-to-one consultations at BIOLOGICS 2024 in London

Heidelberg, Germany: – Specialist bioanalytical contract research organisation (CRO) Bioassay GmbH will be a prominent presence at the upcoming BIOLOGICS UK in London, where it will showcase its latest advances in biological discovery & development.

CSO Dr. Axel Hohenstein and Business Development Director Dr. Luisa Duque will lead the Bioassay team on their stand at Booth 53 in the Exhibition Hall of the Novotel London West, presenting the company’s various strengths in the fields of potency testing and drug development.

Tailored consultations

Bioassay is offering tailored one-to-one consultations on stand and is inviting bookings from professionals interested in assay development & validation, drug efficacy & safety testing, cGMP potency assays, GLP services, and physico-chemical analysis.

Dr. Hohenstein commented: “We look forward to participating in the discussion about the latest innovations and technological advancements at this excellent event.”

“With our focus on potency assays under GMP for biopharmaceuticals, we are able to offer a wide range of highly relevant in-vitro and in-vivo services to clients in the biotech and biologics development sectors,” he added.

About Bioassay GmbH

Bioassay GmbH is a bioanalytical contract laboratory (CRO) specializing in the development, validation and routine performance of bioanalytical assays in the areas of Pharmacology and Toxicology.

Bioassay serves clients in the biotechnology, chemistry and cosmetics sectors and is particularly expert in carrying out potency assays under GMP for biopharmaceuticals, including therapeutic antibodies, hormones and cytokines. It offers a range of services based on in-vivo and in-vitro systems including potency assays (GMP) and toxicity Studies (GLP).

The Bioassay services portfolio focuses on the critical investigation areas of potency, efficacy, and safety, with panels that incorporate a wide range of specialized models and techniques.

Bioassay GmbH was privately founded in 2002 and since 2022 has formed part of the Reaction Biology Corporation. The company is located at Heidelberg’s Technology Park as part of a cluster of innovative biotech companies and institutions with links to Heidelberg University.

Learn more at: https://bioassay-online.com

About BIOLOGICS UK 2024

The annual BIOLOGICS UK conference is billed as Europe’s Premier Meeting for biological drug R&D, providing a forum for biopharma leaders, experts and researchers to join academia for high-level discussions on the latest innovations discovery & development.

BIOLOGICS UK 2024 is a three-day face-to-face event opening March 13 at the Novotel West in Hammersmith, West London, that combines four co-located confeerences: Oxford Global’s flagship 17th Annual Proteins & Antibodies Congress, 11th Annual Peptides Congress, 3rd Annual Oligonucleotides Congress and 2nd Annual Sustainability in Biologics Congress. The  2024 conference will introduce an Innovation & Collaboration track showcasing emerging biotechs & academic spin offs entering the market.

The event is organized by Oxford Global as part of its international BIOLOGICS Series. Further information at: https://www.oxfordglobal.co.uk/biologics-series/

Resources

Click on Meet Bioassay at BIOLOGICS 2024 for further information and links.